Louis Garguilo interviews Massimo Dominici, a professional of eminent status in the CGT field and founder of Rigenerand, about CDMOs. Over the years, Dominici and Mar...

Technologies that gather and store health-related data are generating real-world data (RWD) and real-world evidence (RWE) that are increasingly being applied in healt...

A great many new and varied approaches to clinical trial management are being adopted during the COVID-19 pandemic through the help of virtualisation tools, strong pa...

The Fundamental Aspects of Creating an Agile, Scalable and Flexible Solution Capable of Delivering Better Results than Previous Study Models Bogged down by recruitin...

When the health authorities began placing further emphasis on medicinal product data standards, the overlap between regulatory operations and systems beyond the regul...

Clinical trials themselves have their own complications. Regulatory compliance and safety reporting are of the utmost importance in managing clinical trials. When you...

According to the largest analysis of almost 7,500 clinical and regulatory phase transitions, the likelihood of an oncology drug progressing from Phase I clinical test...

The market for Advanced Therapies has come a long way in the last decade, to the point that some cell and gene therapies have already been approved, and others have n...

Data quality concerns are frequent in schizophrenia clinical trials, causing many to suffer from drug placebo separation. Machine learning offers the opportunity to p...

Machine Learning (ML) and Artificial Intelligence (AI) have come to the forefront of data analytics with the promise of generating new medical insights. However, for ...